Please use this identifier to cite or link to this item:
http://hdl.handle.net/1942/34523
Full metadata record
DC Field | Value | Language |
---|---|---|
dc.contributor.author | VERGUTS, Jasper | - |
dc.contributor.author | Godin, Pierre Arnaud | - |
dc.contributor.author | De Vree, Bart | - |
dc.contributor.author | Donnez, Olivier | - |
dc.contributor.author | Cosyns, Stefan | - |
dc.contributor.author | Luyckx, Mathieu | - |
dc.contributor.author | Nisolle, Michelle | - |
dc.date.accessioned | 2021-07-23T12:23:28Z | - |
dc.date.available | 2021-07-23T12:23:28Z | - |
dc.date.issued | 2019 | - |
dc.date.submitted | 2021-07-12T12:32:52Z | - |
dc.identifier.citation | INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 147 (3) , p. 339 -343 | - |
dc.identifier.uri | http://hdl.handle.net/1942/34523 | - |
dc.description.abstract | Objective To observe alterations in surgical planning that were due to the use of ulipristal acetate (UPA) 5 mg daily for symptomatic uterine fibroids. Methods A prospective cohort trial involving women with symptomatic fibroids was undertaken in 23 clinical practice sites within Belgium between October 1, 2014, and March 31, 2016, to compare initial surgical planning to performed surgical procedures following the use of UPA 5 mg daily for 3 months. Secondary outcomes were surgical complications, reduction in fibroids, bleeding control, and adverse effects. Results Two hundred and twenty-two women were recruited for the trial. The requirement for surgery decreased with the use of UPA, with 54% of women undergoing surgery after treatment. The reduction in surgery performed was lower for women willing to conceive (40%) compared to women who were not (49%). The volume of the fibroids decreased significantly, with the largest measured fibroid decreasing by 50%. Bleeding and pain were significantly decreased with the use of UPA. No major complications were recorded, and no liver function abnormalities were reported during the treatment and in follow-up. Conclusion By administering UPA, the required rate of surgery was significantly decreased. Also, the resulting reduction in size of the fibroids could have the potential benefit of reducing surgery-related complications, and long-term use may be warranted to avoid surgery completely. | - |
dc.language.iso | en | - |
dc.subject.other | Fibroid | - |
dc.subject.other | Hysterectomy | - |
dc.subject.other | Myomectomy | - |
dc.subject.other | Phase 4 | - |
dc.subject.other | Surgery | - |
dc.subject.other | Ulipristal acetate | - |
dc.title | Effect on surgical decisions: Ulipristal acetate as key player in Belgian phase IV registration trial | - |
dc.type | Journal Contribution | - |
dc.identifier.epage | 343 | - |
dc.identifier.issue | 3 | - |
dc.identifier.spage | 339 | - |
dc.identifier.volume | 147 | - |
local.bibliographicCitation.jcat | A1 | - |
local.type.refereed | Refereed | - |
local.type.specified | Article | - |
local.class | IncludeIn-ExcludeFrom-List/ExcludeFromFRIS | - |
dc.identifier.doi | 10.1002/ijgo.12968 | - |
dc.identifier.isi | WOS:000488535100001 | - |
dc.contributor.orcid | Verguts, Jasper/0000-0002-2185-1213 | - |
local.provider.type | wosris | - |
item.fullcitation | VERGUTS, Jasper; Godin, Pierre Arnaud; De Vree, Bart; Donnez, Olivier; Cosyns, Stefan; Luyckx, Mathieu & Nisolle, Michelle (2019) Effect on surgical decisions: Ulipristal acetate as key player in Belgian phase IV registration trial. In: INTERNATIONAL JOURNAL OF GYNECOLOGY & OBSTETRICS, 147 (3) , p. 339 -343. | - |
item.contributor | VERGUTS, Jasper | - |
item.contributor | Godin, Pierre Arnaud | - |
item.contributor | De Vree, Bart | - |
item.contributor | Donnez, Olivier | - |
item.contributor | Cosyns, Stefan | - |
item.contributor | Luyckx, Mathieu | - |
item.contributor | Nisolle, Michelle | - |
item.fulltext | With Fulltext | - |
item.accessRights | Restricted Access | - |
crisitem.journal.issn | 0020-7292 | - |
crisitem.journal.eissn | 1879-3479 | - |
Appears in Collections: | Research publications |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
ijgo.12968.pdf Restricted Access | Published version | 552.83 kB | Adobe PDF | View/Open Request a copy |
WEB OF SCIENCETM
Citations
4
checked on Jul 19, 2024
Page view(s)
54
checked on Sep 7, 2022
Download(s)
4
checked on Sep 7, 2022
Google ScholarTM
Check
Altmetric
Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.